EMJ had the pleasure of interviewing two leading specialists within the field of oncology and oesophageal cancer, Zachary Wilmer Reichenbach, Department of Gastroenterology, Section of Medicine, and the Center for Substance Abuse Research (CSAR), Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA, and Elizabeth Smyth, Cambridge University Hospitals NHS Foundation Trust, UK. The experts shared their perspectives on the treatment landscape of oesophageal cancer.
Latest articles
All articles
15 Mins
31st
March
Endometrial Cancer Research in 2024
Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been associated…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
29th
October
From Podium into Practice: Working Together to Revolutionise Cancer Care in the Real World
Cancer is on course to be the leading cause of death in the EU by 2035. Europe’s population is ageing rapidly, and obesity rates continue…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
8 Mins
29th
October
Novel Approaches to Treat Glioblastoma Multiforme
Glioblastoma multiforme (GBM), central nervous system (CNS) WHO Grade 4 astrocytoma, is an almost uniformly lethal disease…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.